Patent details
EP1749531
Title:
Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
Basic Information
- Publication number:
- EP1749531
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP050168756
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
- French Title of Invention:
- Utilisation d'une suspension orale à base d'acétate de mégestrol pour le traitement de l'asthme bronchique
- German Title of Invention:
- Verwendung von einer oralen Suspension enthaltend Megestrolacetat zur Behandlung von Asthma bronchiale
- SPC Number:
-
Dates
- Filing date:
- 03/08/2005
- Grant date:
- 22/07/2015
- EP Publication Date:
- 22/07/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/02/2007
- EP B1 Publication Date:
- 22/07/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 03/08/2015
- Expiration date:
- 03/08/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/05/2016
-
-
- Name:
- Par Pharmaceutical Inc.
- Address:
- 300 Tice Boulevard, Woodcliff Lake, NJ 07677, United States (US)
Inventor
1
- Name:
- Anker Stefan
- Address:
- Germany (DE)
2
- Name:
- Springer Jochen
- Address:
- Germany (DE)
Classification
- Main IPC Class:
-
A61K 31/57;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |